ContextVision AB (CONTX)

Currency in NOK
4.81
+0.01(+0.21%)
Closed·
CONTX Scorecard
Full Analysis
Management has been aggressively buying back shares
CONTX is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
4.814.81
52 wk Range
4.406.60
Key Statistics
Prev. Close
4.8
Open
4.81
Day's Range
4.81-4.81
52 wk Range
4.4-6.6
Volume
1.15K
Average Volume (3m)
28.48K
1-Year Change
-21.15%
Book Value / Share
1.23
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
CONTX Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
5.50
Upside
+14.35%
Members' Sentiments
Bearish
Bullish
ProTips
Holds more cash than debt on its balance sheet

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

ContextVision AB Company Profile

ContextVision AB (publ), a software company, provides image analysis and imaging for medical systems in South Korea, China, Japan, the United States, and internationally. The company offers image quality solutions for ultrasound, as well as its Rivent platform comprising Rivent, a 2D image enhancement; Rivent Plus, a premium 2D image enhancement product; Rivent 3D, a solution for improving image quality of 3D ultrasound; and Rivent Mobile, a 2D image enhancement for handheld devices for diagnostics in various fields, including radiology, cardiology, women’s health, veterinary medicine, and point of-care applications. It also provides Altumira platform, which features scatter correction and improves radiography by enabling radiation dose reduction while enhancing image quality, such as Altumira for static applications; and Altumira Plus for dynamic applications. In addition, the company offers image quality solutions for MRI including GOPView MRI2Plus for the requirements of each application, sequence type, and protocol; and implementation projects, software updates, and upgrades and product support services. It has a strategic clinical development partnership with the University of Washington School of Medicine for collecting medical imaging data to identify a multiparametric biomarker for the screening and staging of the liver disease MASLD; and research partnership with AMRA Medical to develop AI-powered, organ-specific imaging solutions that enable MASLD screening and physiological quantification. ContextVision AB (publ) was incorporated in 1989 and is headquartered in Stockholm, Sweden.

Compare CONTX to Peers and Sector

Metrics to compare
CONTX
Peers
Sector
Relationship
P/E Ratio
26.7x−2.8x−0.5x
PEG Ratio
−0.45−0.040.00
Price/Book
3.8x0.5x2.6x
Price / LTM Sales
2.9x2.4x3.2x
Upside (Analyst Target)
14.3%32.7%41.4%
Fair Value Upside
Unlock18.0%6.0%Unlock

Analyst Ratings

0 Buy
1 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 5.50
(+14.35% Upside)

Earnings

Latest Release
May 07, 2025
EPS / Forecast
0.01 / 0.10
Revenue / Forecast
26.30M / 37.80M
EPS Revisions
Last 90 days

CONTX Income Statement

FAQ

What Stock Exchange Does ContextVision AB Trade On?

ContextVision AB is listed and trades on the Oslo Stock Exchange stock exchange.

What Is the Stock Symbol for ContextVision AB?

The stock symbol for ContextVision AB is "CONTX."

What Is the ContextVision AB Market Cap?

As of today, ContextVision AB market cap is 372.14M.

What Is ContextVision AB's Earnings Per Share (TTM)?

The ContextVision AB EPS (TTM) is 0.17.

When Is the Next ContextVision AB Earnings Date?

ContextVision AB will release its next earnings report on 25 Aug 2025.

From a Technical Analysis Perspective, Is CONTX a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has ContextVision AB Stock Split?

ContextVision AB has split 1 times.

How Many Employees Does ContextVision AB Have?

ContextVision AB has 42 employees.

What is the current trading status of ContextVision AB (CONTX)?

As of 27 Jul 2025, ContextVision AB (CONTX) is trading at a price of 4.81, with a previous close of 4.80. The stock has fluctuated within a day range of 4.81 to 4.81, while its 52-week range spans from 4.40 to 6.60.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.